Need help? +44 (0) 7457 418426

MEDICINE DETAILS

Humira

Active ingredient: Adalimumab

Neutral reference profile for an independent medicine-access consultancy enquiry about Humira (Adalimumab). No medicine is offered for sale.

NEXT STEP

Choose the strength and pack

✓ If you are unsure, choose “I do not know”.

These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.

RECORDED PRODUCT PROFILE

Humira identity, dosage form and pack information.

The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.

Brand recordHumira
Active ingredientAdalimumab
Dosage formsolution for injection
Recorded options9
Directory areaRheumatology, Dermatology
Catalogue synchronised

Recorded strength and pack options

Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.

  1. 20 mg/0.2 ml · 2 pre-filled syringes Catalogue organisation: AbbVie Deutschland GmbH & Co. KG
  2. 40 mg/0.4 ml · 2 pens Catalogue organisation: AbbVie Deutschland GmbH & Co. KG
  3. 40 mg/0.4 ml · 2 pre-filled syringes Catalogue organisation: AbbVie Deutschland GmbH & Co. KG
  4. 40 mg/0.4 ml solution for injection · 4 pens Catalogue organisation: Abacus Medicine A/S
  5. 40 mg/0.4 ml solution for injection · 4 pre-filled syringes Catalogue organisation: Abacus Medicine A/S
  6. 40 mg/0.4 ml solution for injection · 6 pens Catalogue organisation: CC Pharma GmbH
  7. 40 mg/0.4 ml solution for injection · 6 pre-filled syringes Catalogue organisation: kohlpharma GmbH
  8. 80 mg/0.8 ml · 1 pen Catalogue organisation: AbbVie Deutschland GmbH & Co. KG
  9. 80 mg/0.8 ml solution for injection · 3 pens Catalogue organisation: EMRA-MED Arzneimittel GmbH

SERVICE BOUNDARY

Information checking and independent enquiry support for Humira.

OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.

Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.

CLEAR ANSWERS

Frequently asked questions about Humira

01What is Humira?

This directory record associates the brand name Humira with the active ingredient Adalimumab. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.

02Which Humira strengths and packs are recorded?

The catalogue currently shows: 20 mg/0.2 ml · 2 pre-filled syringes; 40 mg/0.4 ml · 2 pens; 40 mg/0.4 ml · 2 pre-filled syringes; 40 mg/0.4 ml solution for injection · 4 pens. Check the complete strength, dosage form and pack description against the prescription and medicine box.

03Who manufactures Humira?

Catalogue records currently name: AbbVie Deutschland GmbH & Co. KG, Abacus Medicine A/S, CC Pharma GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.

04Do the listed options confirm stock or access?

No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.

05What affects a possible estimated medicine cost for Humira?

A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Humira, payment request, stock guarantee or binding offer.

06Can I buy Humira from this website?

No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.